Kevin Jacobsen won the IMCA award in Paris
"In a way, it's full closure, that the four years of hard work on my PhD finishes with me receiving this award," says MD and PhD Kevin Jacobsen, who is back after a good couple of days in Paris at IMCAS WORLD 2026 - an international conference with over 20,000 participants in dermatological science.
At the conference, he competed against other young research colleagues, but his presentation on a new and advanced scanning method, LC-OCT, which can create digital biopsies of the skin that won the prize.
During the four years he has been working on his PhD, no less than 10 scientific articles have been published on the method.
Important knowledge for everyone
The IMCAS 2026 NextGen Derm Award is a recognition, but also a good example of how dermatologists can benefit from sharing knowledge wherever they work. The 20,000 participants at the IMCAS conference come from clinical dermatology, plastic surgery and aesthetic medicine.
And although Kevin's research is based on the diagnosis of skin cancer (basal cell carcinoma), the results can also be used by dermatologists, who do not work with skin diseases:
- I think that if we can show that the method can be used to investigate the worst case (skin cancer), then it is also useful to investigate skin health and other parameters that may be important in a cosmetic field. In this way, we build bridges between two worlds, both of which are based on scientific data, he says.
Kevin Jacobsen's PhD was carried out at Bispebjerg Hospital under the leadership of principal supervisor, Professor Merete Hædersdal in collaboration with the co-supervisors Associate Professor Jeppe Dyrberg Andersen, PhD Peter Philipsen and PhD Vinzent Kevin Ortner.
